Authors: JONESHUMBLE SA DURCAN MJ LYERLY D NORTON RM TANG FLM RUSSELL AV WATSON MJ GENGO PJ MORGAN PF WANG CM COOPER BR COX RF

Citation: Sa. Joneshumble et al., PRECLINICAL NEUROCHEMICAL AND ELECTROPHYSIOLOGICAL PROFILE OF 1192U90, A POTENTIAL ANTIPSYCHOTIC, Neuropsychopharmacology, 15(3), 1996, pp. 217-230

Authors: DURCAN MJ RIGDON GC NORMAN MH MORGAN PF

Citation: Mj. Durcan et al., IS CLOZAPINE SELECTIVE FOR THE DOPAMINE D-4 RECEPTOR, Life sciences, 57(18), 1995, pp. 275-283

Authors: CRUMRINE RC THOMAS AL MORGAN PF

Citation: Rc. Crumrine et al., ATTENUATION OF P53 EXPRESSION PROTECTS AGAINST FOCAL ISCHEMIC DAMAGE IN TRANSGENIC MICE, Journal of cerebral blood flow and metabolism, 14(6), 1994, pp. 887-891

Authors: JONESHUMBLE SA MORGAN PF COOPER BR

Citation: Sa. Joneshumble et al., THE NOVEL ANTICONVULSANT LAMOTRIGINE PREVENTS DOPAMINE DEPLETION IN C57 BLACK MICE IN THE MPTP ANIMAL-MODEL OF PARKINSONS-DISEASE, Life sciences, 54(4), 1994, pp. 245-252

Authors: JONESHUMBLE SA MORGAN PF

Citation: Sa. Joneshumble et Pf. Morgan, HIGH EXPRESSION OF NITROBENZYLTHIOINOSINE-INSENSITIVE DIPYRIDAMOLE BINDING-SITES IN POSTMORTEM HUMAN EPENDYMAL TISSUE, European journal of pharmacology, 257(3), 1994, pp. 311-314

Authors: DURCAN MJ MORGAN PF VANETTEN ML LINNOILA M

Citation: Mj. Durcan et al., COVARIATION OF ALPHA(2)-ADRENOCEPTOR DENSITY AND FUNCTION FOLLOWING IRREVERSIBLE ANTAGONISM WITH EEDQ, British Journal of Pharmacology, 112(3), 1994, pp. 855-860